David Katz Medtronic PLC Transaction History

Matrix Asset Advisors Inc

$882 Million
Q3 2024

A detailed history of David Katz (Matrix Asset Advisors Inc) transactions in Medtronic PLC stock. As of the latest transaction made, Matrix Asset Advisors Inc holds 308,366 shares of MDT stock, worth $26.7 Million. This represents 3.15% of its overall portfolio holdings.

Number of Shares

308,366

Previous 277,597 11.08%

Holding current value

$26.7 Million

Previous $21.8 Million 27.06%

% of portfolio

3.15%

Previous 2.61%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$76.84 - $91.03 $2.36 Million - $2.8 Million	30,769 Added 11.08%	308,366 $27.8 Million
Q2 2024 Jul 15, 2024	BUY	$78.71 - $87.02 $7.51 Million - $8.3 Million	95,376 Added 52.34%	277,597 $21.8 Million
Q1 2024 Apr 15, 2024	BUY	$82.84 - $88.09 $1.1 Million - $1.17 Million	13,312 Added 7.88%	182,221 $15.9 Million
Q4 2023 Jan 24, 2024	BUY	$69.43 - $83.43 $101,923 - $122,475	1,468 Added 0.88%	168,909 $13.9 Million
Q3 2023 Oct 12, 2023	BUY	$78.22 - $90.4 $766,321 - $885,648	9,797 Added 6.21%	167,441 $13.1 Million
Q2 2023 Jul 18, 2023	BUY	$79.47 - $91.38 $220,370 - $253,396	2,773 Added 1.79%	157,644 $13.9 Million
Q1 2023 Apr 13, 2023	BUY	$76.72 - $87.58 $721,244 - $823,339	9,401 Added 6.46%	154,871 $12.5 Million
Q4 2022 Jan 19, 2023	SELL	$76.18 - $87.74 $68,638 - $79,053	-901 Reduced 0.62%	145,470 $0
Q3 2022 Oct 24, 2022	SELL	$80.75 - $95.31 $2.41 Million - $2.84 Million	-29,844 Reduced 16.94%	146,371 $11.8 Million
Q2 2022 Jul 15, 2022	BUY	$87.4 - $113.09 $4.97 Million - $6.43 Million	56,838 Added 47.61%	176,215 $15.8 Million
Q1 2022 Apr 22, 2022	BUY	$100.58 - $112.38 $12 Million - $13.4 Million	119,377 New	119,377 $13.2 Million

Others Institutions Holding MDT

# of Institutions

2,286

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track David Katz's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Asset Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Asset Advisors Inc and David Katz with notifications on news.

Account